Off-label use of JAK inhibitors can prove beneficial in the treatment of several dermatologic conditions. Casey Butrus, PharmD: I wanted to bring back up the mechanism of action of the topical JAK ...

Please provide your email address to receive an email when new articles are posted on . Despite a class-wide black box warning for prescribing in the early setting, 31% of providers reported ...

Please provide your email address to receive an email when new articles are posted on . The pipeline of Janus kinase inhibitors is robust even as researchers struggle to fully understand how they work ...

PARIS — In a study that employed change in inflammatory biomarkers as a primary endpoint, hair regrowth with ritlecitinib, a dual JAK3/TEC inhibitor, was observed across three types of cicatricial ...

NEW ORLEANS -- Patients with severe alopecia areata had dramatic hair regrowth at 6 months with an investigational Janus kinase (JAK) inhibitor, according to a study reported here. Almost 40% of ...

Eli Lilly and Incyte’s oral JAK inhibitor has shown benefit in hair regrowth in paediatric patients with severe alopecia areata. In the Phase III BRAVE-AA-PEDS trial (NCT05723198) 54.1% and 31% of ...

A Janus kinase (JAK) inhibitor outperformed tumor necrosis factor (TNF) blockers for substantially reducing rheumatoid arthritis (RA) symptoms in patients for whom conventional anti-rheumatic drugs ...

Schematic diagram of the IL-6/JAK/STAT3 signaling pathway activation in mouse liver macrophages. IRs, inhibitory receptors (IRs); ICIs, immune checkpoint inhibitors; IL-6, interleukin-6; ALT, alanine ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., announced the US Food and Drug Administration (FDA) approval of Numelvi ...